Teclistamab Shows Promising Effectiveness for Japanese Myeloma Patients in Long-Term Study A long-term follow-up study on teclistamab shows high response rates and prolonged effects in Japanese patients with refractory multiple myeloma.

Teclistamab Shows Promising Effectiveness for Japanese Myeloma Patients in Long-Term Study #Japan #Tokyo #Multiple_Myeloma #Teclistamab #Janssen_Pharmaceuticals